Moreover, our findings suggest that supplementation with exogenous BMP9 or BMP10 might be a therapeutic strategy in decompensated cirrhosis and in PoPH and HPS, conditions with a major unmet need. The gene discussed is GDF2; the disease is Hermansky-Pudlak syndrome.